The deal follows a 2023 license agreement with Biotheus that granted BioNTech rights to develop and commercialize BNT327/PM8002 outside of Greater China.
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing's print and online coverage.